Egypt's national cancer institute and the largest cancer hospital in Africa and the Arab world, treating patients from across the region since 1969.
The National Cancer Institute of Cairo University was established in 1969 and is the largest specialised cancer institute in Egypt, Africa and the Middle East, providing surgical, medical, radiation and paediatric oncology, haematology and bone marrow transplant, pathology and nuclear medicine, and training the majority of Egypt's oncologists through Cairo University. It hosts a large research programme and tumour registry, contributes to Egypt's national cancer registry and to studies of hepatocellular carcinoma driven by the country's hepatitis C epidemic, schistosomiasis-associated bladder cancer, breast cancer and paediatric leukaemia, and it participates in international multicentre trials and in regional cancer control initiatives with the WHO Eastern Mediterranean office.
Professor who serves as Dean of the National Cancer Institute at Cairo University, Egypt's national cancer teaching hospital and research institute.
Paediatric oncologist who is chief executive of the 57357 group and general manager of Children's Cancer Hospital Egypt 57357 in Cairo.
Shares Sherif Abouel Naga, Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia.
Shares Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Mohamed Abdel Moaty Samra, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, Hepatocellular carcinoma, IMRT / IGRT (modern external beam).
Shares Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, Hepatocellular carcinoma, HR-positive / HER2-negative breast cancer.